Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 6
1985 1
1986 1
1987 1
1988 1
1989 3
1990 2
1991 1
1992 1
1993 2
1995 1
1998 1
1999 2
2003 1
2004 2
2010 1
2011 2
2013 1
2014 1
2015 2
2017 1
2018 2
2019 2
2020 10
2021 1
2022 2
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal analyses reveal immunological misfiring in severe COVID-19.
Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, Ellingson MK, Mao T, Oh JE, Israelow B, Takahashi T, Tokuyama M, Lu P, Venkataraman A, Park A, Mohanty S, Wang H, Wyllie AL, Vogels CBF, Earnest R, Lapidus S, Ott IM, Moore AJ, Muenker MC, Fournier JB, Campbell M, Odio CD, Casanovas-Massana A; Yale IMPACT Team; Herbst R, Shaw AC, Medzhitov R, Schulz WL, Grubaugh ND, Dela Cruz C, Farhadian S, Ko AI, Omer SB, Iwasaki A. Lucas C, et al. Among authors: odio cd. Nature. 2020 Aug;584(7821):463-469. doi: 10.1038/s41586-020-2588-y. Epub 2020 Jul 27. Nature. 2020. PMID: 32717743 Free PMC article.
Cryptic Cachexia.
Odio CD, O'Brien CR, Jacox J, Jain D, Lee AI. Odio CD, et al. N Engl J Med. 2020 Jul 2;383(1):68-74. doi: 10.1056/NEJMcps1817531. N Engl J Med. 2020. PMID: 32609985 No abstract available.
Severe dengue progression beyond enhancement.
Odio CD, Aogo RA, Lowman KE, Katzelnick LC. Odio CD, et al. Nat Immunol. 2023 Dec;24(12):1967-1969. doi: 10.1038/s41590-023-01680-1. Nat Immunol. 2023. PMID: 38012410 No abstract available.
'Mix and Match' vaccination: Is dengue next?
Odio CD, Katzelnick LC. Odio CD, et al. Vaccine. 2022 Oct 26;40(45):6455-6462. doi: 10.1016/j.vaccine.2022.09.007. Epub 2022 Oct 1. Vaccine. 2022. PMID: 36195473 Free PMC article. Review.
Sex differences in immune responses that underlie COVID-19 disease outcomes.
Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, Silva J, Mao T, Oh JE, Tokuyama M, Lu P, Venkataraman A, Park A, Liu F, Meir A, Sun J, Wang EY, Casanovas-Massana A, Wyllie AL, Vogels CBF, Earnest R, Lapidus S, Ott IM, Moore AJ; Yale IMPACT Research Team; Shaw A, Fournier JB, Odio CD, Farhadian S, Dela Cruz C, Grubaugh ND, Schulz WL, Ring AM, Ko AI, Omer SB, Iwasaki A. Takahashi T, et al. Among authors: odio cd. Nature. 2020 Dec;588(7837):315-320. doi: 10.1038/s41586-020-2700-3. Epub 2020 Aug 26. Nature. 2020. PMID: 32846427 Free PMC article.
Multiscale PHATE identifies multimodal signatures of COVID-19.
Kuchroo M, Huang J, Wong P, Grenier JC, Shung D, Tong A, Lucas C, Klein J, Burkhardt DB, Gigante S, Godavarthi A, Rieck B, Israelow B, Simonov M, Mao T, Oh JE, Silva J, Takahashi T, Odio CD, Casanovas-Massana A, Fournier J; Yale IMPACT Team; Farhadian S, Dela Cruz CS, Ko AI, Hirn MJ, Wilson FP, Hussin JG, Wolf G, Iwasaki A, Krishnaswamy S. Kuchroo M, et al. Among authors: odio cd. Nat Biotechnol. 2022 May;40(5):681-691. doi: 10.1038/s41587-021-01186-x. Epub 2022 Feb 28. Nat Biotechnol. 2022. PMID: 35228707 Free PMC article.
Laryngeal tuberculosis.
Ulloa R, Avila ML, Soto M, Paris MM, Faingezicht I, Odio C, Carranza A. Ulloa R, et al. Among authors: odio c. Pediatr Infect Dis J. 1998 Aug;17(8):758-60. doi: 10.1097/00006454-199808000-00022. Pediatr Infect Dis J. 1998. PMID: 9726358 No abstract available.
SARS-CoV-2 infection of the placenta.
Hosier H, Farhadian SF, Morotti RA, Deshmukh U, Lu-Culligan A, Campbell KH, Yasumoto Y, Vogels CB, Casanovas-Massana A, Vijayakumar P, Geng B, Odio CD, Fournier J, Brito AF, Fauver JR, Liu F, Alpert T, Tal R, Szigeti-Buck K, Perincheri S, Larsen C, Gariepy AM, Aguilar G, Fardelmann KL, Harigopal M, Taylor HS, Pettker CM, Wyllie AL, Cruz CD, Ring AM, Grubaugh ND, Ko AI, Horvath TL, Iwasaki A, Reddy UM, Lipkind HS. Hosier H, et al. Among authors: odio cd. J Clin Invest. 2020 Sep 1;130(9):4947-4953. doi: 10.1172/JCI139569. J Clin Invest. 2020. PMID: 32573498 Free PMC article.
Phase 1 trial to model primary, secondary, and tertiary dengue using a monovalent vaccine.
Odio CD, Lowman KE, Law M, Aogo RA, Hunsberger S, Wood BJ, Kassin M, Levy E, Callier V, Firdous S, Hasund CM, Voirin C, Kattappuram R, Yek C, Manning J, Durbin A, Whitehead SS, Katzelnick LC. Odio CD, et al. BMC Infect Dis. 2023 May 23;23(1):345. doi: 10.1186/s12879-023-08299-5. BMC Infect Dis. 2023. PMID: 37221466 Free PMC article. Clinical Trial.
59 results